Drug Profile

CDP 855

Latest Information Update: 21 Sep 2007

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No

Discontinued Multiple sclerosis; Systemic lupus erythematosus; Transplant rejection

01 May 2001 Celltech Chiroscience Discovery is now called Celltech R&D
02 Feb 2000 Medeva has been merged into Celltech Chiroscience, which is now called Celltech Group
22 Oct 1999 Celltech has merged with Chiroscience to form Celltech Chiroscience

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com